Global Prostate Cancer Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

前立腺がん検査の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

◆タイトル:Global Prostate Cancer Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
◆商品コード:GIR8105501
◆調査・発行会社:Global Info Research
◆発行日:2018年10月9日
◆ページ数:129
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール
◆調査対象地域:世界
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥375,840見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥563,760見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥751,680見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Info Researchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは、前立腺がん検査の世界市場について調べ、まとめました。種類別セグメントは、PSAテスト、CTCテスト、免疫組織化学、PCA3テスト、その他等、用途別セグメントは、病院関連研究室、独立診断研究所、がん研究所、その他等に区分しました。前立腺がん検査の世界市場概観、メーカー動向、メーカー別前立腺がん検査シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・前立腺がん検査の市場概観
・前立腺がん検査のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・前立腺がん検査のメーカー別販売動向、市場シェア、市場集中度、競争動向
・前立腺がん検査の世界市場規模
・前立腺がん検査の北米市場分析(アメリカ、カナダ、メキシコ等)
・前立腺がん検査のアメリカ市場規模推移
・前立腺がん検査のカナダ市場規模推移
・前立腺がん検査のメキシコ市場規模推移
・前立腺がん検査のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・前立腺がん検査のドイツ市場規模推移
・前立腺がん検査のイギリス市場規模推移
・前立腺がん検査のロシア市場規模推移
・前立腺がん検査のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・前立腺がん検査の日本市場規模推移
・前立腺がん検査の中国市場規模推移
・前立腺がん検査の韓国市場規模推移
・前立腺がん検査のインド市場規模推移
・前立腺がん検査の東南アジア市場規模推移
・前立腺がん検査の南米市場分析(ブラジル、アルゼンチン等)
・前立腺がん検査の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・前立腺がん検査の種類別分析/市場規模推移(PSAテスト、CTCテスト、免疫組織化学、PCA3テスト、その他)
・前立腺がん検査の用途別分析/市場規模推移(病院関連研究室、独立診断研究所、がん研究所、その他)
・前立腺がん検査の市場予測(地域別予測、種類別予測、用途別予測)
・前立腺がん検査の販売チャネル・代理店・貿易業者・ディーラー分析

Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.

Scope of the Report:

This report studies the Prostate Cancer Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer Testing market by product type and applications/end industries.

The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.

There are many new drugs that have increased the life expectancy of prostate cancer patients and have been approved by the Food & Drug Administration. But these drugs are having a high cost, which is a threat for the patients and the insurers, both. These expensive drugs are not being paid by the insurance companies and the reimbursement level for them is very low. Hence, only few people are capable of affording these drugs. Therefore, because of this high cost, the use of generic drugs is more, and hence, it is hindering the growth of the prostate cancer drugs market.

North America is the leading global market with the largest revenue share in 2017. Due to the rising prevalence of the diseases and high mortality rate of the prostate cancer in the United States, North America is dominating the market. Asia-Pacific is also projected to be the fastest growing region due to the improving healthcare infrastructure and the growing investments by the key market players.

The global Prostate Cancer Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer Testing.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Genomic Health

OPKO

Siemens Healthcare

DiaSorin

bioMeriux

Roche

MDx Health

Beckman Coulter

Myriad Genetics

Ambry Genetics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

PSA Tests

CTC Tests

Immunohistochemistry

PCA3 Tests

Others

Market Segment by Applications, can be divided into

Hospital Associated Labs

Independent Diagnostic Laboratories

Cancer Research Institutes

Others

【レポートの目次】

Table of Contents

1 Prostate Cancer Testing Market Overview

1.1 Product Overview and Scope of Prostate Cancer Testing

1.2 Classification of Prostate Cancer Testing by Types

1.2.1 Global Prostate Cancer Testing Revenue Comparison by Types (2017-2023)

1.2.2 Global Prostate Cancer Testing Revenue Market Share by Types in 2017

1.2.3 PSA Tests

1.2.4 CTC Tests

1.2.5 Immunohistochemistry

1.2.6 PCA3 Tests

1.2.7 Others

1.3 Global Prostate Cancer Testing Market by Application

1.3.1 Global Prostate Cancer Testing Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Associated Labs

1.3.3 Independent Diagnostic Laboratories

1.3.4 Cancer Research Institutes

1.3.5 Others

1.4 Global Prostate Cancer Testing Market by Regions

1.4.1 Global Prostate Cancer Testing Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Testing Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Testing Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Testing Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Testing Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Testing Status and Prospect (2013-2023)

1.5 Global Market Size of Prostate Cancer Testing (2013-2023)

2 Manufacturers Profiles

2.1 Genomic Health

2.1.1 Business Overview

2.1.2 Prostate Cancer Testing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Genomic Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.2 OPKO

2.2.1 Business Overview

2.2.2 Prostate Cancer Testing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 OPKO Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.3 Siemens Healthcare

2.3.1 Business Overview

2.3.2 Prostate Cancer Testing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Siemens Healthcare Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.4 DiaSorin

2.4.1 Business Overview

2.4.2 Prostate Cancer Testing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 DiaSorin Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.5 bioMeriux

2.5.1 Business Overview

2.5.2 Prostate Cancer Testing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 bioMeriux Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.6 Roche

2.6.1 Business Overview

2.6.2 Prostate Cancer Testing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Roche Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.7 MDx Health

2.7.1 Business Overview

2.7.2 Prostate Cancer Testing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 MDx Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.8 Beckman Coulter

2.8.1 Business Overview

2.8.2 Prostate Cancer Testing Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Beckman Coulter Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.9 Myriad Genetics

2.9.1 Business Overview

2.9.2 Prostate Cancer Testing Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Myriad Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

2.10 Ambry Genetics

2.10.1 Business Overview

2.10.2 Prostate Cancer Testing Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Ambry Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

3 Global Prostate Cancer Testing Market Competition, by Players

3.1 Global Prostate Cancer Testing Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Prostate Cancer Testing Players Market Share

3.2.2 Top 10 Prostate Cancer Testing Players Market Share

3.3 Market Competition Trend

4 Global Prostate Cancer Testing Market Size by Regions

4.1 Global Prostate Cancer Testing Revenue and Market Share by Regions

4.2 North America Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

4.3 Europe Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

4.5 South America Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

5 North America Prostate Cancer Testing Revenue by Countries

5.1 North America Prostate Cancer Testing Revenue by Countries (2013-2018)

5.2 USA Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

5.3 Canada Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

5.4 Mexico Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

6 Europe Prostate Cancer Testing Revenue by Countries

6.1 Europe Prostate Cancer Testing Revenue by Countries (2013-2018)

6.2 Germany Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

6.3 UK Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

6.4 France Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

6.5 Russia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

6.6 Italy Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Prostate Cancer Testing Revenue by Countries

7.1 Asia-Pacific Prostate Cancer Testing Revenue by Countries (2013-2018)

7.2 China Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

7.3 Japan Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

7.4 Korea Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

7.5 India Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

8 South America Prostate Cancer Testing Revenue by Countries

8.1 South America Prostate Cancer Testing Revenue by Countries (2013-2018)

8.2 Brazil Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

8.3 Argentina Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

8.4 Colombia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Prostate Cancer Testing by Countries

9.1 Middle East and Africa Prostate Cancer Testing Revenue by Countries (2013-2018)

9.2 Saudi Arabia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

9.3 UAE Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

9.4 Egypt Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

9.5 Nigeria Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

9.6 South Africa Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

10 Global Prostate Cancer Testing Market Segment by Type

10.1 Global Prostate Cancer Testing Revenue and Market Share by Type (2013-2018)

10.2 Global Prostate Cancer Testing Market Forecast by Type (2018-2023)

10.3 PSA Tests Revenue Growth Rate (2013-2023)

10.4 CTC Tests Revenue Growth Rate (2013-2023)

10.5 Immunohistochemistry Revenue Growth Rate (2013-2023)

10.6 PCA3 Tests Revenue Growth Rate (2013-2023)

10.7 Others Revenue Growth Rate (2013-2023)

11 Global Prostate Cancer Testing Market Segment by Application

11.1 Global Prostate Cancer Testing Revenue Market Share by Application (2013-2018)

11.2 Prostate Cancer Testing Market Forecast by Application (2018-2023)

11.3 Hospital Associated Labs Revenue Growth (2013-2018)

11.4 Independent Diagnostic Laboratories Revenue Growth (2013-2018)

11.5 Cancer Research Institutes Revenue Growth (2013-2018)

11.6 Others Revenue Growth (2013-2018)

12 Global Prostate Cancer Testing Market Size Forecast (2018-2023)

12.1 Global Prostate Cancer Testing Market Size Forecast (2018-2023)

12.2 Global Prostate Cancer Testing Market Forecast by Regions (2018-2023)

12.3 North America Prostate Cancer Testing Revenue Market Forecast (2018-2023)

12.4 Europe Prostate Cancer Testing Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Prostate Cancer Testing Revenue Market Forecast (2018-2023)

12.6 South America Prostate Cancer Testing Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Prostate Cancer Testing Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Prostate Cancer Testing Picture

Table Product Specifications of Prostate Cancer Testing

Table Global Prostate Cancer Testing and Revenue (Million USD) Market Split by Product Type

Figure Global Prostate Cancer Testing Revenue Market Share by Types in 2017

Figure PSA Tests Picture

Figure CTC Tests Picture

Figure Immunohistochemistry Picture

Figure PCA3 Tests Picture

Figure Others Picture

Table Global Prostate Cancer Testing Revenue (Million USD) by Application (2013-2023)

Figure Prostate Cancer Testing Revenue Market Share by Applications in 2017

Figure Hospital Associated Labs Picture

Figure Independent Diagnostic Laboratories Picture

Figure Cancer Research Institutes Picture

Figure Others Picture

Table Global Market Prostate Cancer Testing Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Prostate Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Prostate Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Prostate Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Prostate Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Prostate Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Prostate Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)

Table Genomic Health Basic Information, Manufacturing Base and Competitors

Table Genomic Health Prostate Cancer Testing Type and Applications

Table Genomic Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table OPKO Basic Information, Manufacturing Base and Competitors

Table OPKO Prostate Cancer Testing Type and Applications

Table OPKO Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors

Table Siemens Healthcare Prostate Cancer Testing Type and Applications

Table Siemens Healthcare Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table DiaSorin Basic Information, Manufacturing Base and Competitors

Table DiaSorin Prostate Cancer Testing Type and Applications

Table DiaSorin Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table bioMeriux Basic Information, Manufacturing Base and Competitors

Table bioMeriux Prostate Cancer Testing Type and Applications

Table bioMeriux Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Prostate Cancer Testing Type and Applications

Table Roche Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table MDx Health Basic Information, Manufacturing Base and Competitors

Table MDx Health Prostate Cancer Testing Type and Applications

Table MDx Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table Beckman Coulter Basic Information, Manufacturing Base and Competitors

Table Beckman Coulter Prostate Cancer Testing Type and Applications

Table Beckman Coulter Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table Myriad Genetics Basic Information, Manufacturing Base and Competitors

Table Myriad Genetics Prostate Cancer Testing Type and Applications

Table Myriad Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table Ambry Genetics Basic Information, Manufacturing Base and Competitors

Table Ambry Genetics Prostate Cancer Testing Type and Applications

Table Ambry Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)

Table Global Prostate Cancer Testing Revenue (Million USD) by Players (2013-2018)

Table Global Prostate Cancer Testing Revenue Share by Players (2013-2018)

Figure Global Prostate Cancer Testing Revenue Share by Players in 2016

Figure Global Prostate Cancer Testing Revenue Share by Players in 2017

Figure Global Top 5 Players Prostate Cancer Testing Revenue Market Share in 2017

Figure Global Top 10 Players Prostate Cancer Testing Revenue Market Share in 2017

Figure Global Prostate Cancer Testing Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Prostate Cancer Testing Revenue (Million USD) by Regions (2013-2018)

Table Global Prostate Cancer Testing Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Testing Revenue Market Share by Regions (2013-2018)

Figure Global Prostate Cancer Testing Revenue Market Share by Regions in 2017

Figure North America Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Europe Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure South America Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Table North America Prostate Cancer Testing Revenue by Countries (2013-2018)

Table North America Prostate Cancer Testing Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Testing Revenue Market Share by Countries (2013-2018)

Figure North America Prostate Cancer Testing Revenue Market Share by Countries in 2017

Figure USA Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Canada Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Mexico Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Table Europe Prostate Cancer Testing Revenue (Million USD) by Countries (2013-2018)

Figure Europe Prostate Cancer Testing Revenue Market Share by Countries (2013-2018)

Figure Europe Prostate Cancer Testing Revenue Market Share by Countries in 2017

Figure Germany Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure UK Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure France Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Russia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Italy Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Prostate Cancer Testing Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Testing Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Prostate Cancer Testing Revenue Market Share by Countries in 2017

Figure China Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Japan Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Korea Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure India Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Table South America Prostate Cancer Testing Revenue by Countries (2013-2018)

Table South America Prostate Cancer Testing Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Testing Revenue Market Share by Countries (2013-2018)

Figure South America Prostate Cancer Testing Revenue Market Share by Countries in 2017

Figure Brazil Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Argentina Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Colombia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Prostate Cancer Testing Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Prostate Cancer Testing Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Testing Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Prostate Cancer Testing Revenue Market Share by Countries in 2017

Figure Saudi Arabia Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure UAE Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Egypt Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure Nigeria Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Figure South Africa Prostate Cancer Testing Revenue and Growth Rate (2013-2018)

Table Global Prostate Cancer Testing Revenue (Million USD) by Type (2013-2018)

Table Global Prostate Cancer Testing Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Testing Revenue Share by Type (2013-2018)

Figure Global Prostate Cancer Testing Revenue Share by Type in 2017

Table Global Prostate Cancer Testing Revenue Forecast by Type (2018-2023)

Figure Global Prostate Cancer Testing Market Share Forecast by Type (2018-2023)

Figure Global PSA Tests Revenue Growth Rate (2013-2018)

Figure Global CTC Tests Revenue Growth Rate (2013-2018)

Figure Global Immunohistochemistry Revenue Growth Rate (2013-2018)

Figure Global PCA3 Tests Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Table Global Prostate Cancer Testing Revenue by Application (2013-2018)

Table Global Prostate Cancer Testing Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Testing Revenue Share by Application (2013-2018)

Figure Global Prostate Cancer Testing Revenue Share by Application in 2017

Table Global Prostate Cancer Testing Revenue Forecast by Application (2018-2023)

Figure Global Prostate Cancer Testing Market Share Forecast by Application (2018-2023)

Figure Global Hospital Associated Labs Revenue Growth Rate (2013-2018)

Figure Global Independent Diagnostic Laboratories Revenue Growth Rate (2013-2018)

Figure Global Cancer Research Institutes Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Figure Global Prostate Cancer Testing Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Prostate Cancer Testing Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Prostate Cancer Testing Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Prostate Cancer Testing Revenue Market Forecast (2018-2023)

Figure Europe Prostate Cancer Testing Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Prostate Cancer Testing Revenue Market Forecast (2018-2023)

Figure South America Prostate Cancer Testing Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Prostate Cancer Testing Revenue Market Forecast (2018-2023)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[前立腺がん検査の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (Global Prostate Cancer Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 / GIR8105501)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆